Phase II trial of UFT in advanced colorectal and gastric cancer.

A phase II trial of continuous oral therapy with UFT, a combination of uracil and the 5-fluorouracil analogue 1-(2-tetrahydrofuryl)-5-fluorouracil (Futraful, Ftorafur), was conducted in 40 patients with advanced colorectal cancer and 18 patients with advanced gastric cancer. Six partial responses we...

Descripción completa

Detalles Bibliográficos
Autores principales: Malik, S. T., Talbot, D., Clarke, P. I., Osborne, R., Reznek, R., Wrigley, P. F., Slevin, M. L.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1990
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1971578/
https://www.ncbi.nlm.nih.gov/pubmed/2257207

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1971578/
https://www.ncbi.nlm.nih.gov/pubmed/2257207

Ejemplares similares